日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of [(18)F]PSMA-1007 PET/CT in Primary Staging of Prostate Carcinoma: A Systematic Review and Metaanalysis

[(18)F]PSMA-1007 PET/CT 在前列腺癌初次分期中的疗效:系统评价和荟萃分析

Rahbar, Kambiz; Giesel, Frederik L; Herrmann, Ken; Yun, Mijin; Watabe, Tadashi; Rudolph, Ines; Hoepping, Alexander; Maurer, Tobias

A cost-effectiveness study of PSMA-PET/CT for the detection of clinically significant prostate cancer

PSMA-PET/CT在检测临床显著性前列腺癌中的成本效益研究

Privé, Bastiaan M; Govers, Tim M; Israël, Bas; Janssen, Marcel J R; Timmermans, Bart J R; Peters, Steffie M B; de Groot, Michel; Zámecnik, Patrik; Wijn, Stan R W; Hoepping, Alexander; Sedelaar, J P Michiel; Barentsz, Jelle O; van Oort, Inge M; de Rooij, Maarten; Nagarajah, James

Development of [(99m)Tc]TcO-ABX474: Design, Synthesis, and Biological Evaluation of PSMA-Binding Technetium-99m Radioligands for SPECT Imaging of Prostate Cancer

[(99m)Tc]TcO-ABX474 的研制:用于前列腺癌 SPECT 成像的 PSMA 结合锝-99m 放射性配体的设计、合成和生物学评价

Lis, Christian; Ludwig, Friedrich-Alexander; Fischer, Steffen; Ullrich, Martin; Lankau, Hans-Joachim; Sihver, Wiebke; Gündel, Daniel; Joseph, Desna; Meyer, Christoph; Kopka, Klaus; Pietzsch, Jens; Brust, Peter; Hoepping, Alexander

(+)-[(18)F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controls

(+)-[(18)F]氟巴汀作为一种新型α4β2尼古丁乙酰胆碱受体PET配体——首次在β-淀粉样蛋白PET确诊的阿尔茨海默病患者和健康对照组中进行人体脑成像应用的结果

Tiepolt, Solveig; Becker, Georg-Alexander; Wilke, Stephan; Cecchin, Diego; Rullmann, Michael; Meyer, Philipp M; Barthel, Henryk; Hesse, Swen; Patt, Marianne; Luthardt, Julia; Wagenknecht, Gudrun; Sattler, Bernhard; Deuther-Conrad, Winnie; Ludwig, Friedrich-Alexander; Fischer, Steffen; Gertz, Hermann-Josef; Smits, René; Hoepping, Alexander; Steinbach, Jörg; Brust, Peter; Sabri, Osama

In vitro and in vivo Human Metabolism of (S)-[18F]Fluspidine - A Radioligand for Imaging σ1 Receptors With Positron Emission Tomography (PET)

(S)-[18F]氟斯匹定在人体体内和体外的代谢 - 一种用于通过正电子发射断层扫描 (PET) 对 σ1 受体进行成像的放射性配体

Friedrich-Alexander Ludwig, Steffen Fischer, Richard Houska, Alexander Hoepping, Winnie Deuther-Conrad, Dirk Schepmann, Marianne Patt, Philipp M Meyer, Swen Hesse, Georg-Alexander Becker, Franziska Ruth Zientek, Jörg Steinbach, Bernhard Wünsch, Osama Sabri, Peter Brust

Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia

轻度阿尔茨海默病痴呆中α4β2尼古丁乙酰胆碱受体的认知相关性

Sabri, Osama; Meyer, Philipp M; Gräf, Susanne; Hesse, Swen; Wilke, Stephan; Becker, Georg-Alexander; Rullmann, Michael; Patt, Marianne; Luthardt, Julia; Wagenknecht, Gudrun; Hoepping, Alexander; Smits, Rene; Franke, Annegret; Sattler, Bernhard; Tiepolt, Solveig; Fischer, Steffen; Deuther-Conrad, Winnie; Hegerl, Ulrich; Barthel, Henryk; Schönknecht, Peter; Brust, Peter

Exploring the Metabolism of (+)-[18F]Flubatine in Vitro and in Vivo: LC-MS/MS Aided Identification of Radiometabolites in a Clinical PET Study

探索 (+)-[18F] 氟巴汀在体内和体外的代谢:LC-MS/MS 辅助鉴定临床 PET 研究中放射性代谢物

Friedrich-Alexander Ludwig, Steffen Fischer, René Smits, Winnie Deuther-Conrad, Alexander Hoepping, Solveig Tiepolt, Marianne Patt, Osama Sabri, Peter Brust0

Image-Guided Development of Heterocyclic Sulfoxides as Ligands for Tau Neurofibrillary Tangles: From First-in-Man to Second-Generation Ligands

图像引导下开发杂环亚砜作为 Tau 神经原纤维缠结的配体:从首代配体到第二代配体

Waqas Rafique, Vasko Kramer, Tania Pardo, René Smits, Mona M Spilhaug, Alexander Hoepping, Eduardo Savio, Henry Engler, Rodrigo Kuljs, Horacio Amaral, Patrick J Riss

LC-MS Supported Studies on the in Vitro Metabolism of both Enantiomers of Flubatine and the in Vivo Metabolism of (+)-[(18)F]Flubatine-A Positron Emission Tomography Radioligand for Imaging α4β2 Nicotinic Acetylcholine Receptors

LC-MS 支持对氟巴汀两种对映体的体外代谢和 (+)-[(18)F]氟巴汀体内代谢的研究 - 用于对 α4β2 烟碱乙酰胆碱受体进行成像的正电子发射断层扫描放射性配体

Friedrich-Alexander Ludwig, René Smits, Steffen Fischer, Cornelius K Donat, Alexander Hoepping, Peter Brust, Jörg Steinbach

Radiation dosimetry of the α(4)β(2) nicotinic receptor ligand (+)-[(18)F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results

α(4)β(2)尼古丁受体配体(+)-[(18)F]氟巴汀的辐射剂量测定,比较临床前PET/MRI和PET/CT与首次人体PET/CT结果

Kranz, Mathias; Sattler, Bernhard; Tiepolt, Solveig; Wilke, Stephan; Deuther-Conrad, Winnie; Donat, Cornelius K; Fischer, Steffen; Patt, Marianne; Schildan, Andreas; Patt, Jörg; Smits, René; Hoepping, Alexander; Steinbach, Jörg; Sabri, Osama; Brust, Peter